Martin Haluzı́k

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass

Oksana Gavrilova, Martin Haluzı́k, Kimihiko Matsusue et al. · Journal of Biological Chemistry · 2003 · 761 citations · Full text

Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

Kimihiko Matsusue, Martin Haluzı́k, Gilles Lambert et al. · Journal of Clinical Investigation · 2003 · 535 citations · Full text

Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

Kimihiko Matsusue, Martin Haluzı́k, Gilles Lambert et al. · Journal of Clinical Investigation · 2003 · 535 citations · Full text

Enhanced insulin sensitivity in mice lacking ganglioside GM3

Tadashi Yamashita, Akira Hashiramoto, Martin Haluzı́k et al. · Proceedings of the National Academy of Sciences · 2003 · 519 citations · Full text